| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2020 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 3,634 | $233.74 | $849,417.56 | -1.2% | |
| Feb 25, 2020 | Kewalramani Reshma55 | EVP And CMO | Sell | 1,191 | $237.10 | $282,390.63 | -1.1% | |
| Feb 25, 2020 | Tatsis Ourania48 | SVP, CRO | Sell | 1,296 | $233.17 | $302,186.72 | -1.6% | |
| Feb 25, 2020 | Altshuler David48 | EVP, Global Research And CSO | Sell | 1,894 | $235.40 | $445,853.28 | -1.3% | |
| Feb 25, 2020 | Silva Paul M | SVP &Controller | Sell | 780 | $232.86 | $181,628.57 | -1.0% |